Another possible target is IRAK2 encoding the interleukin-1 receptor-associated kinase 2 that was reported to participate in the IL1-induced up-regulation of NF-kappaB, a pathway known to be involved in the pathogenesis of psoriasis [35]. Here, IRAK2 is linked to psoriasis.